The RAR-related orphan receptor gamma t (RORγt) is a nuclear receptor required for generating IL-17-producing CD4 + Th17 T cells, which are essential in host defense and may play key pathogenic roles in autoimmune diseases. Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol and lipid metabolism. Here, we describe the identification of several naturally occurring oxysterols as RORγt agonists. The most potent and selective activator for RORγt is 7β, 27-dihydroxycholesterol (7β, 27-OHC). We show that these oxysterols reverse the inhibitory effect of an RORγt antagonist, ursolic acid, in RORγ-or RORγt-dependent cell-based reporter assays. These ligands bind directly to recombinant RORγ ligand binding domain (LBD), promote recruitment of a coactivator peptide, and reduce binding of a corepressor peptide to RORγ LBD. In primary cells, 7β, 27-OHC and 7α, 27-OHC enhance the differentiation of murine and human IL-17-producing Th17 cells in an RORγt-dependent manner. Importantly, we showed that Th17, but not Th1 cells, preferentially produce these two oxysterols. In vivo, administration of 7β, 27-OHC in mice enhanced IL-17 production. Mice deficient in CYP27A1, a key enzyme in generating these oxysterols, showed significant reduction of IL-17-producing cells, including CD4
Edited by Peter S. Kim, Stanford University School of Medicine, Stanford, CA, and approved July 10, 2014 (received for review December 10, 2013) The RAR-related orphan receptor gamma t (RORγt) is a nuclear receptor required for generating IL-17-producing CD4 + Th17 T cells, which are essential in host defense and may play key pathogenic roles in autoimmune diseases. Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol and lipid metabolism. Here, we describe the identification of several naturally occurring oxysterols as RORγt agonists. The most potent and selective activator for RORγt is 7β, 27-dihydroxycholesterol (7β, 27-OHC). We show that these oxysterols reverse the inhibitory effect of an RORγt antagonist, ursolic acid, in RORγ-or RORγt-dependent cell-based reporter assays. These ligands bind directly to recombinant RORγ ligand binding domain (LBD), promote recruitment of a coactivator peptide, and reduce binding of a corepressor peptide to RORγ LBD. In primary cells, 7β, 27-OHC and 7α, 27-OHC enhance the differentiation of murine and human IL-17-producing Th17 cells in an RORγt-dependent manner. Importantly, we showed that Th17, but not Th1 cells, preferentially produce these two oxysterols. In vivo, administration of 7β, 27-OHC in mice enhanced IL-17 production. Mice deficient in CYP27A1, a key enzyme in generating these oxysterols, showed significant reduction of IL-17-producing cells, including CD4
+ and γδ + T cells, similar to the deficiency observed in RORγt knockout mice. Our results reveal a previously unknown mechanism for selected oxysterols as immune modulators and a direct role for CYP27A1 in generating these RORγt agonist ligands, which we propose as RORγt endogenous ligands, driving both innate and adaptive IL-17-dependent immune responses.
I L-17-producing CD4
+ Th17 cells are essential in protective immunity against extracellular bacterial and fungal infections but also, play key pathogenic roles in autoimmune diseases, such as psoriasis and multiple sclerosis. RAR-related orphan receptor gamma t (RORγt) is an orphan nuclear receptor expressed in several immune cell types, including CD4 + Th17 cells. Because of its essential role in driving IL-17 production, RORγt represents a potential target for therapeutic intervention, and a number of antagonists have been published that inhibited Th17 cell differentiation (1-3). However, the nature of RORγt endogenous ligands remains unknown, although accumulating evidence suggested the existence of such ligands. For example, crystal structures of the ligand binding domain of RORγ clearly showed a well-defined pocket that could accommodate a cholesterol or 25-hydroxycholesterol (OHC) molecule (4) . Purified naïve CD4
+ T cells can be activated in culture to differentiate into IL-17-producing cells, suggesting that these cells have the capacity to produce endogenous RORγt ligand(s). In addition, IL-17-producing mouse RORγt + innate lymphoid cells, believed to be essential in orchestrating immunity at mucosal sites, including intestine and lung, were shown to be generated in vivo under germfree conditions (5) . Identification of the endogenous agonist ligand(s) and understanding of how the ligand engages and activates RORγt may, therefore, offer critical insights into the rational design of RORγt modulators to block pathogenic IL-17-producing cells in disease.
Oxysterols are oxygenated derivatives of cholesterol or byproducts of cholesterol synthesis (6) (7) (8) (9) . Some oxysterols serve as key intermediates for bile acid and steroid synthesis and function as signaling molecules or receptor ligands modulating cell proliferation and apoptosis, lipid and cholesterol synthesis, transportation and metabolism, and immune responses. For example, certain oxysterols have been shown to serve as endogenous ligands of EBI2 receptor (10, 11) , activate the liver X receptor (12) , function as a selective estrogen receptor modulator (13) , or affect Hedgehog signaling by binding to the Smoothened molecule (14) . In addition, several oxysterols were previously shown to function as RORγ or RORα inverse agonists (such as 7-hydroxylated oxysterols) or 24(S)-OHC agonists (such as 25-OHC) (4, 15, 16) . However, their role as endogenous RORγ, RORγt, or RORα ligands in vivo was not clearly shown.
We have identified a number of naturally occurring oxysterols as RORγt agonists. Although we cannot exclude at present the existence of additional endogenous agonists of RORγt, here we show that two 7, 27-dihydroxycholesterols (i.e., 7β, 27-OHC and 7α, 27-OHC) are strong candidates as endogenous RORγt
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To establish the selectivity of the RORγt-active 27-OHCs, we tested them for potential agonist activity in several nuclear receptor (NR) reporter assays (SI Appendix, Fig. S2 ). While 27-OHC showed weak activity for LXRα and 27-OHC and 7-keto, 27-OHC showed moderate activity for LXRβ, 7β, 27-OHC and 7α, 27-OHC were inactive up to 30 μM. 27-OHC also showed weak activity for ERβ, but 7β, 27-OHC, 7α, 27-OHC, and 7-keto, 27-OHC were inactive against ERα or ERβ. In addition, none of the 27-OHCs showed agonist activity up to 30 μM against other NRs, including PPARα, PPARβ, PPARγ, CAR, GR, and bile acid-sensing FXR. When tested in antagonist mode (SI Appendix, Fig. S2 ), 7-keto, 27-OHC showed inhibition of all NRs tested, except LXRα and LXRβ. Neither 7β, 27-OHC nor 7α, 27-OHC showed any antagonist activity against all NRs tested except for ERβ, against which all 27-OHCs showed some activity, particularly 7-keto, 27-OHC and 27-OHC. Taken together, 7β, 27-OHC and 7α, 27-OHC seemed to be the most selective RORγt agonists among the four 27-OHCs in cell-based reporter assays.
Direct Binding of Oxysterols to RORγ LBD. We next measured direct binding of oxysterols to recombinant RORγ LBD protein in the absence or presence of a peptide from the steroid receptor coactivator-1 (SRC1) using the thermal shift readout ThermoFluor (17-19) (SI Appendix, Fig. S3A ). Direct binding of oxysterols to recombinant LBD of RORα and RORβ in the presence of SRC1 peptide was also examined (SI Appendix, Fig.  S3A ). Consistent with their activities in the cell-based chimeric RORγ-dependent reporter assay, 27-OHCs were among the most potent binders to RORγ LBD, with a rank order of 7β, 27-OHC > 7-keto, 27-OHC > 27-OHC > 7α, 27-OHC. The presence of SRC1 peptide did not affect binding to RORγ LBD by 27-OHCs except 27-OHC, which showed reduced affinity, suggesting that this most abundant oxysterol in the body is unlikely to be an endogenous RORγ agonist. When tested against the LBDs of RORα and RORβ in the presence of SRC1, some selectivity was observed: 7α, 27-OHC was inactive in binding to RORα and RORβ, and 7β, 27-OHC was inactive in binding to RORα. In contrast, 7-keto, 27-OHC bound to all three ROR LBD proteins and showed the highest affinity for RORα in the presence of SRC1 peptide. Taken together, these findings suggest that 7β, 27-OHC and 7α, 27-OHC are more selective agonist ligands for RORγt than 27-OHC or 7-keto, 27-OHC.
25-OHC was previously shown to form a complex with RORγ LBD, and 3 H-labeled 25-OHC exhibited specific binding to recombinant RORγ LBD in vitro (4), which showed a K d of 10 nM in a saturation binding assay (SI Appendix, Fig. S3B ). Consistent with their activities in the cell-based RORγ reporter assay, the RORγ-active oxysterols effectively competed with 3 H-25-OHC for binding to recombinant RORγ LBD (Fig. 1A) . The same rank of potency for the four 27-OHCs was observed as that determined using the ThermoFluor readout, with 7β, 27-OHC being most potent in competing with 3 H-25-OHC for binding to RORγ LBD. Moreover, we found that RORγ-active oxysterols (i.e., 7β, 27-OHC and 7α, 27-OHC but much less for 7α, 25-OHC) enhanced binding of RORγ LBD to NCOA3 while decreasing binding to NCORNR (Fig. 1B) using surface plasmon resonance as readout. For the reporter assay, oxysterols (starting at 6 μM; 1:3 serial dilutions) were tested in duplicates in the presence (0% of response) or absence (100% of response) of 1 μM UA. For the mouse total or naïve CD4 + T cells under Th17 condition increased the number of IL-17A-producing cells with minimal effect or increasing number of IFN-γ-producing cells. This finding became more obvious when 7β, 27-OHC or 7α, 27-OHC was added to Tcell cultures in the presence of UA ( Fig. 2A and SI Appendix, Figs. S4A and S6). As observed for murine cells, 7β, 27-OHC and 7α, 27-OHC but not 7α, 25-OHC promoted differentiation of human naïve CD4
+ T cells to IL-17-producing Th17 cells in culture and reversed the inhibitory effect of UA (Fig. 2B and SI Appendix, Fig.  S4B ). It was unclear whether 27-OHC affected IL-17 production, because it showed strong cytotoxicity for mouse and human T cells in culture. 7-Keto, 27-OHC was much less efficacious than 7α/β, 27-OHC in promoting the appearance of IL-17-producing mouse or human Th17 cells (SI Appendix, Fig. S7 ), which was expected from the findings with the full-length RORγt reporter assay. The effect of 7β, 27-OHC or 7α, 27-OHC on Th17 cell polarization seems to depend on RORγt, because no increase in the number of IL-17 + cells was observed when RORγt-deficient mouse CD4 + T cells were cultured in the presence of these oxysterols ( Fig. 2A) . Because RORα expression was intact in the RORγt-deficient CD4 + T cells, the lack of any apparent effect of 7β, 27-OHC or 7α, 27-OHC in those cells further suggested that they were not functional RORα agonists, consistent with ThermoFluor binding data.
Mice Deficient in CYP27A1 Show Reductions in IL-17 Production.
Mitochondrial sterol 27-hydroxylase (CYP27A1) (SI Appendix, Fig. S8 ) is a key enzyme in bile acid synthesis and the production of 27-OHCs in vivo (6, (19) (20) (21) . Impaired formation of 27-OHC in Cyp27a1 KO mice was previously reported (22) . We have confirmed this observation by liquid chromatography (LC) MS/MS analysis and extended previous findings by detecting reductions in 7β, 27-OHC, and 7α, 27-OHC in Cyp27a1 KO mice (Fig. 3A and SI Appendix, Fig. S9 and Table S4 ). In comparison, the levels of 7-OHCs and 25-OHCs (e.g., 7α-OHC, 7β-OHC, 7α, 25-OHC, and 7β, 25-OHC) were elevated in Cyp27a1 KO mice (Fig. 3A and SI Appendix, Fig. S10 and Table S4 ). We observed a reduction in the number of IL-17 + cells in KO mice (Fig. 3B) , including spleen CD4 + and γδ + T cells. Cyp27a1 KO splenocytes showed diminished mRNA levels for IL-17 and other Th17-related genes, such as IL-17F and IL-22, by RT-PCR (Fig. 3B ). Similar observations with RORγt KO splenocytes (SI Appendix, Fig. S11 ) suggest that CYP27A1 may, indeed, affect IL-17 production through an RORγt-dependent mechanism. Although by FACS analysis, the number of spleen or peritoneal IFN-γ + CD4
+ or γδ + T cells in Cyp27a1 KO seemed to be similar to WT, RT-PCR analysis indicated that there was an increase in IFN-γ mRNA in Cyp27a1 KO splenocytes, which was observed in RORγt KO splenocytes (Fig. 3B and SI Appendix, Fig. S11 ).
We next examined whether CYP27A1 was required for differentiation of highly purified mouse naïve CD4 + T cells into Th17 cells in vitro. Cyp27a1 KO-naïve CD4
+ T cells showed a dramatically reduced capacity for Th17 differentiation and increased Th1 differentiation in culture (Fig. 3C) . Different from RORγt-deficient CD4 + T cells ( Fig. 2A) , addition of 7β, 27-OHC to naïve CD4 + T cells from Cyp27a1 KO mice restored IL-17-producing cells. To determine whether CYP27A1 was also required for in vivo differentiation of antigen-specific Th17 cells, we immunized mice with ovalbumin/complete Freund's adjuvant (OVA/CFA) followed by ex vivo restimulation of draining lymph node cells with ovalbumin in culture. The draining lymph node cells from Cyp27a1 KO mice showed reduced numbers of both IL-17 + and IL-22 + CD4 + T cells and increased numbers of IFN-γ + cells as observed in vitro (Fig. 3D) , which was also confirmed by determination of the levels of IL-17A, IL-22, and IFN-γ in culture supernatants by ELISA (Fig. 3D) . In addition, in vivo dosing of synthetic 7β, 27-OHC through s.c. injections in mice increased the number of IL-17 + cells in both CD4 + and γδ + T cells, while showing no effect on IFN-γ + cells (Fig. 4A) . Dosing of synthetic 7β, 27-OHC also boosted in vivo differentiation of Th17 cells and production of IL-17 in culture in the OVA/CFA immunization model, reversing the effect of UA dosed in those same animals (Fig. 4B) . In this particular study, production of IFN-γ by T cells in ex vivo culture was also increased but to a smaller extent than that of IL-17 (∼2× increase for IFN-γ compared with >35× increase for IL-17 production). Taken together, these findings suggest a role for Cyp27a1 and 7β/α, 27-OHC in driving IL-17 production in vivo in mice. In comparison, the number of CD4 + IL-17 + cells was normal in splenocytes deficient in CH25H, a key enzyme catalyzing the formation of 25-OHC from cholesterol (6, 7) (SI Appendix, Fig. S10 ). Because the levels of 25-OHCs were elevated in Cyp27a1 KO mice (SI Appendix, Figs. S9 and S10 and Table S4 ), these results indicate that 25-OHCs are unlikely to function as endogenous RORγt agonists.
7β, 27-OHC and 7α, 27-OHC Are Preferentially Produced by Mouse Th17 Cells. Because highly purified CD4 + T cells can be differentiated into IL-17-producing cells in culture, we reasoned that differentiating Th17 cells had the capacity to synthesize endogenous RORγt agonist ligands. Interestingly, we noted that both 7β-OHC and 7α-OHC, when tested in mouse CD4
+ T-cell cultures, were active in reversing the inhibitory effect of UA on IL-17 production, with similar efficacy to their 27-dihydroxylated analogs (SI Appendix, Fig. S12A ). This finding was in contrast to the observation in the RORγt reporter assay, where 7-OHCs were, in general, much weaker agonists. This observation may be because of conversion of 7-OHCs to 7, 27-OHCs by T cells in culture, because neither 7β-OHC nor 7α-OHC enhanced IL-17 production in CYP27A1-deficient CD4 + T cells (SI Appendix, Fig. S12B ). To directly test this hypothesis, we investigated whether mouse Th17 cells could convert exogenously added 3 H-7α-OHC or 7β-OHC into 7, 27-OHCs in culture. Mouse Th17 cells but not Th1 cells significantly converted 3 H-7β-OHC into more hydrophilic ones (Fig. 5A) . Similarly, 3 H-7α-OHC was converted by Th17 cells to a lower extent but not by Th1 cells. HPLC analysis of the product from 3 H-7β-OHC resulted in its separation into peaks A and B (Fig. 5B) . Peak B is likely 7β, 27-OHC, because it was absent from the converted product of cultured Cyp27a1 KO CD4
+ T cells; also, its identity was confirmed by MS analysis. Peak A was complex as suggested by MS studies. Its generation seems to be partially dependent on CYP27A1: this peak was reduced but not absent from the converted product in Cyp27a1 KO CD4 + T cells. Similar products were observed when 3 H-7β-OHC was added to cultures of COS7 cells transiently expressing human CYP27A1 (Fig. 5C ). These findings suggest that mouse Th17 but not Th1 cells preferentially produce 7β, 27-OHC from exogenously added 7β-OHC. To a lesser extent, they likely produced 7α, 27-OHC from exogenously added 7α-OHC in a CYP27A1-dependent manner. Interestingly, the expression of Cyp27a1 was enriched in mouse Th17 cells, whereas the expression of Ch25h was higher in mouse Th1 cells (SI Appendix, Fig. S13A ). Expected from this observation, higher levels of endogenous 25-OHCs were observed in in vitro differentiated Th1 cells (∼50% IFN-γ + at harvest) (SI Appendix, Fig. S13B ). Among 27-OHCs, in vitro differentiated Th17 cells (∼30% IL-17 + at harvest) produced significantly higher levels of 7β, 27-OHC relative to Th1 cells. No apparent difference in the levels of 7α, 27-OHC and higher levels of 27-OHC were seen in Th1 cells. Whether the lower level of 27-OHC in Th17 was caused by conversion to 7β, 27-OHC is unclear, although neither Th17 nor Th1 cells showed much capacity for conversion of 3 H-27-OHC in vitro (SI Appendix, Fig. S14 ). Taken together, our findings suggest that Th17 cells have higher capacity to produce 7β, 27-OHC, although it is less clear whether the same applies for 7α, 27-OHC. Statistics by two-tailed, unpaired Student t test. *P < 0.05; **P < 0.01; ***P < 0.001.
Discussion
We have shown that 7β, 27-OHC and 7α, 27-OHC are RORγt agonist ligands and provided evidence suggesting their role as endogenous drivers of Th17 differentiation. Both bound to recombinant RORγ LBD protein directly and were selective against other nuclear receptors tested. They were active in enhancing RORγt-dependent reporter expression and IL-17 production in primary mouse and human Th17 cells in vitro. In vivo dosing of 7β, 27-OHC in mice increased the number of IL-17 + cells. Production of these two oxysterols in vivo requires CYP27A1, a key bile acid synthesis enzyme. Mice deficient in CYP27A1 showed reduced levels of 7β, 27-OHC and 7α, 27-OHC and importantly, decrease in IL-17-producing cells. Thus, naïve Cyp27a1 KO CD4 + T cells are defective in their ability to differentiate into Th17 cells in vitro, which could be rescued by addition of 7β, 27-OHC. In addition, in vivo antigen-specific generation of Th17 cells was also defective in CYP27A1-deficient mice in a priming model. The overall profile of 7α, 27-OHC seemed to be less favorable than that of 7β, 27-OHC; however, we cannot exclude it as a potential candidate endogenous RORγt agonist ligand.
Although a deficiency in IL-17-producing cells was consistently observed in younger Cyp27a1 KO mice (<8 wk), one intriguing observation was that, as these KO mice age, the deficiency became less obvious. Some animals even seemed to develop a phenotype resembling autoinflammation (e.g., splenomegaly was observed on necropsy, and production of cytokines, including IL-17A and IFN-γ, increased). When tested in immune disease models of longer duration, such as collagen-induced arthritis, our preliminary data indicated no difference between WT and Cyp27a1 KO mice or even some exacerbation in KO mice. Although these observations seem to contradict our finding that these mice were deficient in IL-17 production, it is worth noting that certain IL-17-or IL-22-producing innate lymphocytes might play a regulatory role, and dysregulation of those cells could account, in part, for the apparent autoinflammatory phenotype in aged KO animals. Nonetheless, the observed IL-17 production in aged CYP27A1-deficient mice suggests the existence of endogenous RORγt agonists other than 27-OHCs, exogenous RORγt ligands, or RORγt-independent mechanisms. These alternative hypotheses require additional investigation.
Endogenous levels of 7β, 27-OHC and maybe 7α, 27-OHC seem to be in the same ranges of binding affinity values determined using the 3 H-25-OHC/RORγ LBD competitive binding assay. Based on our LC/MS/MS studies, the levels of endogenous 7β, 27-OHC and 7α, 27-OHC in total spleen or in vitro-generated Th17 cells are in single to double digit nanomolar ranges (∼3-12 nM for 7β, 27-OHC and 1-35 nM for 7α, 27-OHC). In the 3 H-25-OHC/RORγ LBD competitive binding assay, 7β, 27-OHC showed higher affinity (K i = 120 nM) and 7α, 27-OHC showed lower affinity (K i = 1,008 nM) than unlabeled 25-OHC (K i = 280 nM) (Fig. 1A) . Based on the K d value of 10 nM for 3 H-25-OHC in this assay (SI Appendix, Fig. S3B ), we estimate that K d values of 7β, 27-OHC and 7α, 27-OHC are ∼4 and ∼36 nM, respectively. Additional studies will be needed to confirm this estimation.
We have further showed that cultured mouse Th17 cells but not Th1 cells showed enhanced capability to convert exogenously added 7β-OHC or 7α-OHC to 7, 27-OHCs in culture. This finding explained why 7-OHCs were also active in reversing the inhibitory effect of UA in mouse T cells and indicates that T cells themselves can synthesize these endogenous RORγt agonists. Addition of 3 H-labled 27-OHC to Th17 or Th1 cells did not support generation of 7β, 27-OHC or 7α,27-OHC from exogenously added 27-OHC (SI Appendix, Fig. S13 ). It may be due to low expression of CYP7B1 in mouse T cells, which is the enzyme required for converting 27-OHC into 7α,27-OHC.
Because of its high cytotoxicity in primary mouse and human T cells in culture, we could not show whether 27-OHC had any agonist activity in enhancing IL-17 production. However, there are a number of findings suggesting that 27-OHC might not be an endogenous RORγt agonist. In the presence of SRC1, 27-OHC bound to RORγ LBD with reduced affinity. In addition, 27-OHC also showed partial agonist activity against LXRα, LXRβ, and ERβ in cell-based reporter assays. We cannot rule out that 27-OHC may still have a role in modulating RORγt function in cells because of binding RORγ LBD in the absence of SRC1 with relatively high affinity and because of its abundance at steady state.
Among other naturally occurring oxysterols, we showed that 25-OHCs are unlikely endogenous agonists for RORγt. First, they were less potent or efficacious than their 27-hydroxylated derivatives in the RORγ/γt reporter assays and the RORγ LBD binding assay. Second, none of the 25-OHCs were active in enhancing IL-17 production in T cells. Furthermore, in Cyp27a1 KO mice, which had decreased IL-17-producing cells, the levels of all 25-OHCs were increased. Finally, in Ch25h KO mice, in which 25-OHCs production was defective, normal or slightly increased numbers of IL-17-producing cells were observed.
After 27-OHC, 7α-OHC and 24(S)-OHC are the next two most abundant oxysterols in vivo. In the RORγ reporter assay, both seemed to show partial efficacy at highest noncytotoxic concentrations compared with the efficacy observed for 27-OHCs. 7α-OHC failed to show significant agonist activity in enhancing IL-17 production in Cyp27a1 KO CD4 + T cells, and its level was highly increased in Cyp27a1 KO mice, suggesting that it is not an RORγt agonist in vivo. Both 7α-OHC and 24(S)-OHC were previously reported by others (15, 16) to function as inverse agonists for RORγ. It is possible that they may play a role in regulating the effect of full endogenous agonists, such as 7β, 27-OHC and 7α, 27-OHC, by competing for binding to RORγ or RORγt. We hypothesize that the balance between the abundant oxysterols, such as 27-OHC, 7α-OHC, and 24(S)-OHC, and the low levels of 7β, 27-OHC and 7α, 27-OHC at steady state maintains the homeostatic state of IL-17-producing innate cells. However, T-cell activation under Th17 conditions may favor generation of high levels of 7β, 27-OHC and 7α, 27-OHC, which serve as RORγt agonists to program Th17 differentiation and drive IL-17 production.
Nonetheless, we must point out that, although our data support that 7β, 27-OHC and 7α, 27-OHC are strong candidates as endogenous RORγt ligands, additional investigations are needed in many aspects. Because of the observations associated with aged Cyp27a1 KO mice and the labile nature of oxysterols, such as 7β, 27-OHC, it has been difficult to explore these tools in more relevant in vivo IL-17-dependent models, such as experimental allergic encephalomyelitis or susceptibility to Citrobacter infection. Moreover, we cannot exclude the possibility that endogenous molecules other than the oxysterols that we studied or pathogen-derived factors may also act as exogenous RORγt ligands in activating or modulating RORγt in IL-17-producing cells. In addition, although we have focused on examining effects of oxysterols in RORγt-dependent functions in IL-17-producing cells, we also need to point out that the same oxysterols may serve as endogenous RORγ agonists. To this end, it will be of interest to investigate whether some of the abnormalities observed in CYP27A1-deficient humans or mice might be partially caused by RORγ functional defects.
Materials and Methods
Reagents. Oxysterols, antibodies, cytokines, and other chemicals are described in SI Appendix.
Recombinant LBD of RORγ, RORα, and RORβ. The generation of the LBD proteins of human RORs are described in SI Appendix.
RORγ-or RORγt-Dependent Luciferase Reporter Assays. Cell-based reporter assays were performed by transiently transfecting HEK293T cells as described in SI Appendix.
Nuclear Receptor Reporter Assays for Selectivity. Cell-based reporter assay kits were purchased from Indigo Biosciences, Inc. or Invitrogen and performed according to the manufacturer's instructions as described in SI Appendix.
RORγ LBD Surface Plasmon Resonance Assay. Biacore studies were performed by Biosensor Tools as described in SI Appendix.
ThermoFluor Binding Assay. ThermoFluor experiments were carried out as described in SI Appendix.
Synthesis of 7α/β/keto, 25-OHC, and 7β, 27-OHC. Detailed synthesis methods are described in SI Appendix.
Extraction and Quantification of Oxysterols with LC/MS/MS. Detailed methods are described in SI Appendix.
Mice. Ch25h KO mice, Cyp27a1 KO mice, RORγt KO mice, and C57BL/6J control mice, as described in SI Appendix, were purchased from The Jackson Laboratory.
Mouse Th17 Cell Activation and Differentiation in Vitro. Isolation and in vitro Th17 differentiation of total or naïve mouse CD4 + T cells were carried as described in SI Appendix.
Gene Expression Studies in Mouse Splenocytes or Th17 Cells. RNA extraction using the RNeasy Plus Mini Kit (Qiagen) and real-time RT-PCR using the commercial Taqman RNA-to-Ct 1-Step Kit (Life Technologies) were carried out as described in SI Appendix.
Conversion of

